Hyaluronidase in the correction of hyaluronic acid-based fillers: A review and a recommendation for use

Journal of Cosmetic Dermatology

Volumn 8, Issue 4, 2009, Pages

  Rzany, Berthold ^a   Becker Wegerich, Petra ^b   Bachmann, Frank ^a   Erdmann, Ricardo ^a   Wollina, Uwe ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Ästhetik und Laserzentrum ^*  (Switzerland)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Hyaluronic acid; Hyaluronidase

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CIPROFLOXACIN; DESINFITRAL; FILLER; GLYCERYL TRINITRATE; HYALURONIC ACID; HYALURONIDASE; HYLENEX; LEVOFLOXACIN; LIDOCAINE; PREDNISONE; STEROID; UNCLASSIFIED DRUG; HYALURONOGLUCOSAMINIDASE;

ANAPHYLAXIS; BURNING SENSATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; ECCHYMOSIS; ERYTHEMA; ESTHETICS; FOLLOW UP; HUMAN; HYDROLYSIS; INFLAMMATION; NECROSIS; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN NODULE; ESTHETIC SURGERY; PRACTICE GUIDELINE;

COSMETIC TECHNIQUES; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; PRACTICE GUIDELINES AS TOPIC;

EID: 76849083965     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00462.x     Document Type: Review

References (27)

1. De Maio M, Rzany B. Injectable Fillers in Aesthetic Medicine. Heidelberg: Springer; 2006; ISBN 3-540-23941-3.
2. Monheit GD, Coleman KM. Hyaluronic acid fillers. Dermatol Ther 2006; 19(3): 141-50.
3. Narins RS, Dayan SH, Brandt FS, Baldwin EK. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008; 34(Suppl. 1): S2-8.
4. Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch Facial Plast Surg 2005; 7(4): 231-7.
5. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 2006; 22(5): 335-41.
6. Soparkar CN, Patrinely JR, Skibell BC, Tower RN. Hyaluronidase and Restylane. Arch Facial Plast Surg 2007; 9(4): 299-300.
7. Agrawal A, McLure HA, Dabbs TR. Allergic reaction to hyaluronidase after a peribulbar injection. Anaesthesia 2003; 58(5): 493-4.
8. Ahluwalia HS, Lukaris A, Lane CM. Delayed allergic reaction to hyaluronidase: a rare sequel to cataract surgery. Eye 2003; 17(2): 263-6.
9. Leibovitch I, Tamblyn D, Casson R, Selva D. Allergic reaction to hyaluronidase: a rare cause of orbital inflammation after cataract surgery. Graefes Arch Clin Exp Ophthalmol 2006; 244(8): 944-9.
10. Müller U, Bircher A, Bischof M. Allergisches Angioödem nach zahnärztlicher Applikation eines Lokalanästhetikum und Hyaluronidase enthaltenden Vorspritzmittels. Schweiz Med Wochenschr 1986; 116: 1810-1813.
11. Andre P, Flechet ML. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection. J Cosmet Dermatol 2008; 7(2): 136-8.
12. European Pharmacopoeia 6.0: European Directorate for the Quality of Medicines; 2008; 978-92-871-6328-8 (online). http://www.digento.de/titel/103336.html.
13. West DC, Shaw DM, Lorenz P, Adzick NS, Longaker MT. Fibrotic healing of adult and late gestation fetal wounds correlates with increased hyaluronidase activity and removal of hyaluronan. Int J Biochem Cell Biol 1997; 29(1): 201-10.
14. Schwartz DM, Jumper MD, Lui GM, Dang S, Schuster S, Stern R. Corneal endothelial hyaluronidase: a role in anterior chamber hyaluronic acid catabolism. Cornea 1997; 16(2): 188-91.
15. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007; 23: 435-61.
16. Breu W. Hyaluronidase. Wien Med Wochenschr 1952; 102(23): 435-7.
17. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004; 114(1): 277.
18. Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid-induced Tyndall effects. Lasers Surg Med 2006; 38(3): 202-4.
19. Hirsch RJ, Cohen JL. Challenge: Correcting superficially placed hyaluronic acid. Skin Aging 2007; 15: 36-8.
20. Yocum RC, Kennard D, Heiner LS. Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: a doubleblind, placebo-controlled clinical trial. J Infus Nurs 2007; 30(5): 293-9.
21. Soparkar CN, Patrinely JR, Tschen J. Erasing restylane. Ophthal Plast Reconstr Surg 2004; 20(4): 317-8.
22. Andre P, Levy PM. Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection. J Cosmet Dermatol 2007; 6(3): 159-62.
23. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 1: 893-7.
24. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007; 33(3): 357-60.
25. Hirsch RJ, Lupo M, Cohen JL, Duffy D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol 2007; 6(3): 325-8.
26. Soparkar CN, Patrinely JR. Managing inflammatory reaction to restylane. Ophthal Plast Reconstr Surg 2005; 21(2): 151-3.
27. Becker-Wegerich P. New indications for Hyaluronic acid of the NASHA-gel-generation-highlights from aesthetical dermatology in clinical daily routine. J Dtsch Dermatol Ges 2008; 6(Suppl. 3): S3-20.